Clinical use of and future perspectives on antiarrhythmic drugs
Authors:
- 2 September 2008
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 64 (12) , 1139-1146
Abstract
Cardiac arrhythmias are associated with significant morbidity and mortality. Antiarrhythmic drug therapy was traditionally the mainstay of arrhythmia treatment; however, the limited efficacy and proarrhythmic potential of conventional antiarrhythmic drugs has generated interest in new approaches to the treatment of arrhythmias. Over the last decade, there has been improved characterization of the molecular pathways that culminate in arrhythmias. By analyzing mechanisms that increase susceptibility to arrhythmias in individuals with genetic syndromes, it might be possible to not only improve current therapies but also to develop novel approaches to treat and prevent common arrhythmias.Keywords
This publication has 50 references indexed in Scilit:
- Pharmacotherapy of atrial fibrillation: an old option with new possibilitiesExpert Opinion on Pharmacotherapy, 2008
- Common NOS1AP Variants Are Associated With a Prolonged QTc Interval in the Rotterdam StudyCirculation, 2007
- ACC/AHA/ESC 2006 Guidelines for the Management of Patients With Atrial FibrillationCirculation, 2006
- A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarizationNature Genetics, 2006
- Freedom From Atrial Tachyarrhythmias After Catheter Ablation of Atrial FibrillationCirculation, 2005
- Himalayan T Waves in the Congenital Long-QT SyndromeCirculation, 2005
- Drug-Induced Prolongation of the QT IntervalNew England Journal of Medicine, 2004
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Preliminary Report: Effect of Encainide and Flecainide on Mortality in a Randomized Trial of Arrhythmia Suppression after Myocardial InfarctionNew England Journal of Medicine, 1989
- Timolol-Induced Reduction in Mortality and Reinfarction in Patients Surviving Acute Myocardial InfarctionNew England Journal of Medicine, 1981